The stock of Quest Diagnostics, Inc (DGX) has seen a -1.51% decrease in the past week, with a 1.95% gain in the past month, and a 6.27% flourish in the past quarter. The volatility ratio for the week is 1.47%, and the volatility levels for the past 30 days are at 1.56% for DGX. The simple moving average for the last 20 days is 0.03% for DGX stock, with a simple moving average of 8.32% for the last 200 days.
Is It Worth Investing in Quest Diagnostics, Inc (NYSE: DGX) Right Now?
The price-to-earnings ratio for Quest Diagnostics, Inc (NYSE: DGX) is above average at 22.38x, Company’s 36-month beta value is 0.49.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 1 as “overweight,” 10 as “hold,” and 0 as “sell.”
The public float for DGX is 111.01M, and currently, short sellers hold a 3.28% ratio of that floaft. The average trading volume of DGX on June 27, 2025 was 1.23M shares.
DGX) stock’s latest price update
The stock of Quest Diagnostics, Inc (NYSE: DGX) has decreased by -0.89 when compared to last closing price of 178.65. Despite this, the company has experienced a -1.51% fall in its stock price over the last five trading sessions. zacks.com reported 2025-06-26 that Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Analysts’ Opinion of DGX
Many brokerage firms have already submitted their reports for DGX stocks, with Redburn Atlantic repeating the rating for DGX by listing it as a “Buy.” The predicted price for DGX in the upcoming period, according to Redburn Atlantic is $195 based on the research report published on April 02, 2025 of the current year 2025.
Citigroup, on the other hand, stated in their research note that they expect to see DGX reach a price target of $185. The rating they have provided for DGX stocks is “Neutral” according to the report published on March 04th, 2025.
Leerink Partners gave a rating of “Outperform” to DGX, setting the target price at $174 in the report published on January 06th of the current year.
DGX Trading at 1.11% from the 50-Day Moving Average
After a stumble in the market that brought DGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.91% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DGX starting from DELANEY MARK E, who sale 874 shares at the price of $175.72 back on May 12 ’25. After this action, DELANEY MARK E now owns 8,372 shares of Quest Diagnostics, Inc, valued at $153,579 using the latest closing price.
DELANEY MARK E, the SVP & Chief Commercial Officer of Quest Diagnostics, Inc, sale 874 shares at $175.31 during a trade that took place back on May 13 ’25, which means that DELANEY MARK E is holding 7,498 shares at $153,221 based on the most recent closing price.
Stock Fundamentals for DGX
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.33 for the gross margin
The net margin for Quest Diagnostics, Inc stands at 0.09. The total capital return value is set at 0.1. Equity return is now at value 13.35, with 6.00 for asset returns.
Based on Quest Diagnostics, Inc (DGX), the company’s capital structure generated 0.49 points at debt to capital in total, while cash flow to debt ratio is standing at 0.23. The debt to equity ratio resting at 0.95. The interest coverage ratio of the stock is 5.65.
Currently, EBITDA for the company is 1.89 billion with net debt to EBITDA at 3.27. When we switch over and look at the enterprise to sales, we see a ratio of 2.57. The receivables turnover for the company is 7.24for trailing twelve months and the total asset turnover is 0.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
In a nutshell, Quest Diagnostics, Inc (DGX) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
